2nd October, Melbourne, Australia – Q-Sera Pty Ltd (Q-Sera) is pleased to announce the addition of international consultant and expert in the field of blood collection tubes, Franz E. Kirchmeir to our growing company to further R&D efforts and assist in the commercialization of the RAPClot™ technology.
Franz was previously the Director of Business Development at Greiner Bio-One Preanalytics at their global headquarters in Austria. He brings 20 years’ experience in the pre-analytical business sector including blood collection tubes, as well as extensive knowledge in R&D management, business development and strategic management. Q-Sera is pleased to welcome Franz to the team to help bring our technology into international markets.
Q-Sera has patented a novel class of coagulation agents for use in blood collection tubes. Q-Sera’s coagulation agent RAPClot™, a prothrombin activator, is produced recombinantly from modified cell lines using standard pharmaceutical manufacturing processes; meaning that it can be available at the required scale and low cost for use in a universal blood collection tube.
Blood collection tubes coated with RAPClot™ have been shown to produce high quality serum for accurate analyses faster than standard tubes, including cases where the blood samples contain anti-coagulants. Q-Sera is developing the RAPClot™ technology to improve the efficiency and reduce costs in the healthcare system, driving better outcomes for patients through faster testing turnaround times enabling quicker lifesaving decisions.
Franz will bring to Q-Sera expertise in international business development, technical engineering and R&D management in the field of blood collection tubes in addition to key relationships with potential international partners. He will assist Q-Sera to further develop and commercialize Q-Sera’s revolutionary technology and introduce its benefits to global markets.
Michael Grant, CEO of Q-Sera, said, “We are absolutely pleased and excited to work with Franz, whose experience and expertise will be invaluable to Q-Sera’s efforts to bring RAPClot™ blood collection tubes into the global market.”.